MIEF2 — Mitochondrial Elongation Factor 2 (MiD50)

MIEF2 — Mitochondrial Elongation Factor 2 (MiD50)

Overview

MIEF2 (Mitochondrial Elongation Factor 2), also known as MiD50 (Mitochondrial Dynamics Protein of 50 kDa) and SMCR7, encodes a critical mitochondrial outer membrane protein that plays essential roles in regulating mitochondrial dynamics. Mitochondria are dynamic organelles that continuously undergo fission (division) and fusion (merging), a process essential for cellular health, energy metabolism, and quality control. MIEF2 functions as a molecular adaptor that recruits the large GTPase Drp1 (Dynamin-related protein 1) to the mitochondrial surface to initiate fission.

MIEF2 — Mitochondrial Elongation Factor 2 (MiD50)

Overview

MIEF2 (Mitochondrial Elongation Factor 2), also known as MiD50 (Mitochondrial Dynamics Protein of 50 kDa) and SMCR7, encodes a critical mitochondrial outer membrane protein that plays essential roles in regulating mitochondrial dynamics. Mitochondria are dynamic organelles that continuously undergo fission (division) and fusion (merging), a process essential for cellular health, energy metabolism, and quality control. MIEF2 functions as a molecular adaptor that recruits the large GTPase Drp1 (Dynamin-related protein 1) to the mitochondrial surface to initiate fission.

The balance between mitochondrial fission and fusion is critical for neuronal survival. In neurodegenerative diseases including Parkinson's disease (PD), Alzheimer's disease (AD), and amyotrophic lateral sclerosis (ALS), mitochondrial dynamics are profoundly disrupted. MIEF2 sits at the intersection of these pathways, making it an important protein for understanding disease mechanisms and developing therapeutic interventions.

This gene has attracted significant attention because of its direct interaction with the PINK1/Parkin pathway, which is central to familial PD. Loss of MIEF2 function impairs mitophagy (mitochondrial quality control), leading to accumulation of dysfunctional mitochondria—a hallmark of neurodegeneration.

Gene Information

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">MIEF2 — Mitochondrial Elongation Factor 2</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>MIEF2</td></tr>
<tr><td><strong>Protein Product</strong></td><td>MiD50 (Mitochondrial dynamics protein of 50 kDa)</td></tr>
<tr><td><strong>Also Known As</strong></td><td>SMCR7, Mid51</td></tr>
<tr><td><strong>Chromosome</strong></td><td>17p13.1</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[84790](https://www.ncbi.nlm.nih.gov/gene/84790)</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000146070</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q8N5Z0](https://www.uniprot.org/uniprot/Q8N5Z0)</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>[Parkinson's Disease](/diseases/parkinsons-disease), [Alzheimer's Disease](/diseases/alzheimers-disease), [ALS](/diseases/amyotrophic-lateral-sclerosis), Mitochondrial Disorders</td></tr>
</table>
</div>

Molecular Function and Mechanism

Structure and Topology

MIEF2 (MiD50) is a mitochondrial outer membrane protein with several key features:

• N-terminal mitochondrial targeting sequence: Directs protein to mitochondria
• Transmembrane domain: Anchors protein in the outer membrane
• Cytosolic domain: Interacts with Drp1 and other proteins
• Flexible linker region: Connects membrane and cytosolic domains

Role in Mitochondrial Fission

Mitochondrial fission is executed by the large GTPase Drp1, which forms ring-like structures around mitochondria to mediate division. However, Drp1 must first be recruited to the mitochondrial surface. MIEF2 performs this critical function:

Interaction with PINK1/Parkin Pathway

MIEF2 directly interfaces with the PINK1/Parkin mitophagy pathway:

• PINK1 phosphorylation: Upon mitochondrial damage, PINK1 accumulates on the outer membrane
• Parkin recruitment: PINK1 phosphorylates ubiquitin and Parkin, activating it
• Mitochondrial fission: Activated Parkin ubiquitinates MIEF2 and other fission proteins
• Quality control: Fission enables segregation of damaged mitochondrial segments for degradation

Expression Pattern

Tissue Distribution

MIEF2 is widely expressed but shows particular importance in tissues with high energy demands:

| Tissue | Expression | Notes |
|--------|------------|-------|
| Brain | High | Neurons require constant energy |
| Heart | High | Continuous cardiac function |
| Muscle | High | High metabolic demand |
| Liver | Moderate | Metabolic functions |
| Kidney | Moderate | Various transport functions |

Cellular Localization

Within neurons, MIEF2 localizes to:

• Mitochondrial outer membrane: Throughout neuronal processes
• Synaptic mitochondria: Enriched at synapses where energy demand is highest
• Axonal mitochondria: Critical for axonal maintenance

Role in Mitochondrial Quality Control

Mitophagy Overview

Mitophagy is a specialized form of autophagy that selectively removes damaged mitochondria. This process is essential for:

• Removing dysfunctional mitochondria
• Maintaining cellular health
• Preventing accumulation of ROS-producing organelles

MIEF2 in Mitophagy

MIEF2 contributes to mitophagy through:

Loss of MIEF2 function impairs mitophagy, leading to accumulation of dysfunctional mitochondria.

Mitochondrial Dynamics in Quality Control

The fission/fusion cycle integrates with quality control:

• Fusion: Allows mixing of mitochondrial contents, complementing function
• Fission: Generates units for possible removal
• Selective removal: Damaged segments are eliminated via mitophagy
• Rejuvenation: Healthy mitochondria resume fusion and function

Parkinson's Disease

PINK1/Parkin Connection

PD is strongly linked to mitochondrial dysfunction. MIEF2 sits at the interface of the PINK1/Parkin pathway:

• PINK1 mutations: Cause early-onset familial PD
• Parkin mutations: Cause autosomal recessive PD
• MIEF2 regulation: Both pathways affect MIEF2 function

• MIEF2 is downregulated in PD patient brain
• Overexpression of MIEF2 can protect dopaminergic neurons
• Loss of MIEF2 enhances vulnerability to mitochondrial toxins

Dopaminergic Neuron Vulnerability

Dopaminergic neurons in the substantia nigra are particularly vulnerable:

• High energy requirements
• Complex axonal arborization
• Reliance on mitophagy for survival
• Exposure to oxidative stress from dopamine metabolism

Therapeutic Implications

MIEF2 represents a therapeutic target for PD:

• Gene therapy: Increasing MIEF2 expression
• Small molecule activators: Enhancing MIEF2 function
• Combination approaches: Targeting multiple aspects of mitophagy

Alzheimer's Disease

Amyloid-Beta Effects

In AD, amyloid-beta (Aβ) directly affects mitochondrial dynamics:

• Aβ accumulation: In mitochondria and at synapses
• Drp1 recruitment: Enhanced, leading to excessive fission
• Mitochondrial fragmentation: Characteristic finding in AD neurons
• Energy deficits: Resulting from impaired mitochondrial function

Tau Pathology

Tau pathology also impacts mitochondrial dynamics:

• Tau mislocalization: To dendritic mitochondria
• Drp1 recruitment: Tau interacts with Drp1
• Fission/fusion imbalance: Contributing to dysfunction

Therapeutic Strategies

Approaches targeting mitochondrial dynamics in AD include:

• Drp1 inhibitors: Reduce excessive fission
• MIEF2 modulators: Normalize dynamics
• Combination approaches: With anti-amyloid therapies

Amyotrophic Lateral Sclerosis (ALS)

Mitochondrial Dysfunction in ALS

ALS also features prominent mitochondrial abnormalities:

• Motor neuron vulnerability: High energy requirements
• Mitochondrial fragmentation: Observed in models and patients
• Quality control failure: Impaired mitophagy

MIEF2 Contributions

MIEF2 dysfunction may contribute to ALS pathogenesis:

• Enhanced fission
• Impaired quality control
• Energy deficits in motor neurons

Other Neurodegenerative Conditions

Huntington's Disease

Mitochondrial dysfunction is a hallmark of Huntington's disease:

• Mutant huntingtin: Affects mitochondrial dynamics proteins
• Drp1 hyperactivity: Contributes to fragmentation
• Energy deficits: Impaired ATP production

Mitochondrial Disorders

Primary mitochondrial diseases also involve MIEF2:

• Leigh syndrome: Often involves fission defects
• MELAS: Mitochondrial encephalomyopathy
• External ophthalmoplegia: CPEO

Interactions with Other Proteins

MiD49 (MIEF1)

MIEF2 works closely with its paralog MiD49 (encoded by MIEF1):

• Heterodimer formation: Complexes provide more efficient recruitment
• Functional redundancy: Partial compensation possible
• Differential regulation: Each responds to different signals

Drp1 (DNM1L)

Drp1 is the primary effector of MIEF2 function:

• Direct binding: Through MIEF2 cytosolic domain
• GTPase regulation: Modulates Drp1 activity
• Oligomerization: Promotes Drp1 assembly

Other Dynamics Proteins

MIEF2 interacts with the broader mitochondrial dynamics network:

• OPA1: Inner membrane fusion protein
• Mfn1/2: Outer membrane fusion proteins
• Fis1: Alternative fission adaptor

Therapeutic Implications

Targeting Mitochondrial Dynamics

MIEF2 and related proteins represent therapeutic targets:

| Strategy | Approach | Status |
|---------|---------|--------|
| Gene therapy | Increase MIEF2 expression | Preclinical |
| Drp1 inhibitors | Reduce excessive fission | Clinical trials |
| MIEF2 modulators | Direct activation | Research |
| Combination approaches | Multi-target strategies | Emerging |

Biomarker Potential

MIEF2 may serve as a biomarker:

• Blood cells: Peripheral measure
• CSF: Central nervous system involvement
• Imaging: PET-based approaches (experimental)

Research Tools and Models

Genetic Models

Key models for studying MIEF2:

• Knockout mice: Embryonic lethal, highlighting essential function
• Conditional knockouts: Tissue-specific deletion
• iPSC models: Neurons from patients

Chemical Modulators

Tools for studying mitochondrial dynamics:

• Mdivi-1: Drp1 inhibitor
• Mitochondrial division inhibitors: Related compounds
• Fission inducers: For controlled studies

Future Directions

Outstanding Questions

Emerging Research

• Single-cell approaches: Cell-type specific dysfunction mapping
• Structural biology: Understanding MIEF2-Drp1 interaction
• Gene therapy: Viral vector approaches for delivery

Cross-links

• [Drp1 Protein](/proteins/drp1-protein)
• [Mitochondrial Dynamics Pathway](/mechanisms/mitochondrial-dynamics-pathway)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [PINK1](/genes/pink1)

References

• [Genes Index](/genes)
• [Proteins Index](/proteins)
• [Diseases Index](/diseases)
• [Mechanisms Index](/mechanisms)

Pathway Diagram

The following diagram shows the key molecular relationships involving MIEF2 — Mitochondrial Elongation Factor 2 (MiD50) discovered through SciDEX knowledge graph analysis: